Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

por Iqbal, S., Goldman, B., Fenoglio-Preiser, C. M., Lenz, H. J., Zhang, W., Danenberg, K. D., Shibata, S. I., Blanke, C. D.
Publicado 2011

Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030)

por Louie, S G, Ely, B, Lenz, H-J, Albain, K S, Gotay, C, Coleman, D, Raghavan, D, Shields, A F, Gold, P J, Blanke, C D
Publicado 2013

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma

por El-Khoueiry, A B, Rankin, C, Siegel, A B, Iqbal, S, Gong, I-Y, Micetich, K C, Kayaleh, O R, Lenz, H-J, Blanke, C D
Publicado 2014